A great-grandfather becomes one of the first in the UK to be treated for a stroke, using stem cells.

Watch video: http://www.bbc.co.uk/news/health-36450628.

It is hoped that ReNeuron’s treatment will “at the very least” arrest the deterioration in eyesight caused by the disease and in the best case restore sight.

ReNeuron was one of the best performers on the AIM market after a successful placing which had the backing of star fund manager, Neil Woodford.

After fund manager Neil Woodford bought a 20% stake in ReNeuron, CFO Michael Hunt discusses the opportunities for the company.

Visit page: http://reut.rs/14J5zqc